BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Healthtrust Education - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Healthtrust Education
X-ORIGINAL-URL:https://education.healthtrustpg.com
X-WR-CALDESC:Events for Healthtrust Education
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240207T080000
DTEND;TZID=America/Chicago:20240207T170000
DTSTAMP:20230907T165236Z
CREATED:20230907T164406Z
LAST-MODIFIED:20230907T165236Z
UID:10001373-1707292800-1707325200@education.healthtrustpg.com
SUMMARY:On-Demand Program:  "Leveraging Compression Therapy for Reducing Lower Extremity Edema"
DESCRIPTION:3M*Healthcare Academy and HMP Education present…“Leveraging Compression Therapy for Reducing Lower Extremity Edema” \nJoin our presenters to discuss strategies for Reducing Lower Extremity Edema. \nLearning Objectives  |  At the end of this session\, participants should be able to: \n\nRecognize the critical importance of compression therapy as the cornerstone of VLU management\nReview best practices in compression therapy and skin and wound care to optimize VLU management\nExplore clinical decision-making prior to implementing compression to manage edema across the spectrum\nEvaluate the science and clinical application of 2-layer compression therapy\nInvestigate the use of compression wraps to manage edema associated with diabetic ulcers\n\nPresenters: \n \nEmily Greenstein\, APRN\, CNP\, CWON-AP\, FACCWS  |  Nurse Practitioner  |  Sanford Health  |  Rasmussen College  |  West Fargo\, North Dakota \n \nTerry Treadwell\, M.D.\, FACS\, FAAWC  |  General Surgeon\, Wound & Burn Care Specialist  |  Montgomery\, Alabama \nTarget Audience:  This activity is designed for physicians\, nurses\, nurse practitioners\, physician assistants & podiatrists across all practice settings involved  in the prevention\, treatment & management of patients with wounds. \nContinuing Education:  In support of improving patient care\, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC)\, to provide continuing education for the healthcare team.  Note: This statement is not an indication of approved credits. Please visit the accreditation page for full accreditation details\, including credit types and totals\, for this activity.\nPODIATRY\nHMP Education is approved by the Council on Podiatric Medical Education\nas a provider of continuing education in podiatric medicine. HMP Education has approved this internet enduring activity for a maximum of 1.00 continuing education contact hour. \nThis on-demand webcast is available with synchronized slides and video. \nTo be eligible for credit\, participants must complete the educational activity\, complete the 4-question post-test with a minimum score of 70%\, and complete the activity evaluation form. Upon completing the activity\, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit. \nRelease Date: August 31\, 2023\nExpiration Date: November 30\, 2024\nEstimated Time to Complete: 1.00 hour \nThere is no fee associated with this activity. \nQuestions: please call 609-371-1137 or email accreditation@hmpglobal.com. \nHardware/Software Requirements: \nThe activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox\, Google Chrome\, or Safari. A PDF reader is required for print publications. \nProvided by HMP Education\, an HMP Global Company. Supported by an educational grant from 3M Health Care\, Medical Solutions Division. \n* NOTE: This is a supplier and/or industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products\, services\, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier\, product\, service\, drug\, brand or approach.
URL:https://education.healthtrustpg.com/calendar/on-demand-program-leveraging-compression-therapy-for-reducing-lower-extremity-edema/2024-02-07/
CATEGORIES:Nursing,Other,Pharmacy,Physicians,Podiatry
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240207T120000
DTEND;TZID=America/Chicago:20240207T130000
DTSTAMP:20240212T222537Z
CREATED:20231229T211152Z
LAST-MODIFIED:20240212T222537Z
UID:10003606-1707307200-1707310800@education.healthtrustpg.com
SUMMARY:"Direct Oral Anticoagulants in Liver Disease:  Stirring the Clotroversy"
DESCRIPTION:HealthTrust presents…“Direct Oral Anticoagulants in Liver Disease: Stirring the Clotroversy” \n**Due to technical issues with WebEx\, this session was rescheduled to Friday\, March 15. We apologize for any inconvenience.** \nDirect oral anticoagulants (DOACs) are first line therapy for most thromboembolic disease states including nonvalvular atrial fibrillation and venous thromboembolism. However\, patients with liver disease and cirrhosis were excluded from all pivotal randomized controlled trials assessing the efficacy and safety of DOACs. Their efficacy and safety remain largely unknown in this patient population. Future trials are needed to further define the efficacy\, safety and possible dose adjustments of DOACs in patients with advanced liver disease (especially in those with Child-Pugh class C). The presenter will provide an overview of current literature for the use of DOACs in advanced liver disease. Specifically\, for which subsets of populations that the data is the strongest. \nLearning Objectives for Pharmacists & Nurses   |  At the end of this session\, participants should be able to: \n\nRecall the pathophysiology of chronic liver disease and its relationship to both elevated risk of thromboembolic events and bleeding.\nIdentify the pharmacokinetics of key direct oral anticoagulants (DOACs) and their relation to the effects of chronic liver disease.\nRecognize which subgroups of patients with chronic liver disease have data for the safe and efficacious use of direct oral anticoagulants (DOACs) in thromboembolic conditions.\n\nPresenter: \n \n  \nGregory Taylor\, PharmD  |  PGY-2 Pharmacy Resident  |  Princeton Baptist Medical Center \nTarget Audience: Pharmacists & Nurses \nCE Credit: Approved for Pharmacists & Nurses \nThis program is approved for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is 0863-9999-24-004-L01-P. The activity is approved for 1 hour (.1 CEUs) of continuing education credit for pharmacists and nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN\, provider approved by the California Board of Registered Nursing\, Provider Number CEP13019\, for 1 contact hour. 1.0 contact hours approved for Nurses. \nNote about CE credit: If you plan to obtain credit for a live session\, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone\, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
URL:https://education.healthtrustpg.com/calendar/novel-oral-anticoagulants-in-liver-disease-stirring-the-clotroversy/
CATEGORIES:Nursing,Pharmacy
END:VEVENT
END:VCALENDAR